SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA

People with type 2 diabetes (T2D) with concomitant chronic kidney disease (CKD) and cardiovascular (CV) disease are at increased risk for recurrent CV events and hypoglycemia. Treatment of these individuals is clinically challenging, where the evidence-base for safety and efficacy of glucose lowerin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Endocr Soc
Päätekijät: Kahn, Steven, Perkovic, Vlado, Johansen, Odd Erik, Rosenstock, Julio, McGuire, Darren, Toto, Robert, Nikolaus, Marx, Alexander, John, Zinman, Bernard, Pfarr, Egon, Schnaidt, Sven, Meinicke, Thomas, George, Jyothis, von Eynatten, Max, Cooper, Mark, Wanner, Christoph
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Endocrine Society 2019
Aiheet:
Cardiovascular Endocrinology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553362/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB015
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia